The report highlights that insulin-derived amyloidosis can mimic other injection-site reactions and should be considered when ...

Activating two somatostatin receptors enhances amyloid beta breakdown and improves memory in models of Alzheimer’s disease.

An experimental Alzheimer's disease drug from Eisai (4523.T) and Biogen (BIIB.O) slowed cognitive decline in a closely watched trial but may carry a risk of dangerous side effects for certain patients ...

For decades, Alzheimer’s disease has been framed as a one‑way slide, with treatments aiming only to slow the descent. Now a ...

Review clinical classifications, diagnostic procedures, and management strategies for cardiomyopathy and heart failure in this comprehensive overview.

Some trials show modest improvements in fasting glucose, lipids, or inflammatory markers, possibly via antioxidant or ...

Nose picking is common, but research suggests aggressive or frequent picking that damages nasal tissue may allow bacteria to ...

Subtle behavior changes in older dogs can signal a brain disorder. New guidelines explain what to watch for and how CCDS is ...

Everywhere you look, there is a great deal of fear about the possibility of developing dementia as you get older. A new study ...

Celia Walden investigates the British brands who are heralding a new era of ageing – gracefully, joyfully and with evidence ...

Published in Brain Stimulation, the Baycrest/Rotman team used fMRI to show rapid CSF dynamics changes after brief pulsed PBM ...

I inherited $400,000 and I have absolutely no idea what to do. I'm retired and 72. I've been diagnosed with Alzheimer's Disease. I'm completely asymptomatic and it's not known if and/or when it will ...